Phase 1 study assessing the pharmacokinetics of NEX-22A in subjects with T2D

Status

Withdrawn

Phases

Phase 1

Study type

Interventional

Source

EU CTIS

Registry ID

CTIS2023-508054-25-00

Acronym

NEX-22-01

Enrollment

Registered

2024-02-21

Start date

Unknown

Completion date

Unknown

Last updated

2024-02-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Type 2 diabetes

None listed

Sex/Gender

All

Age

18 Years to No maximum

Germany

None listed

Source: EU CTIS · Data processed: Feb 4, 2026